US 10,376,553 B2
Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, Magnoliae flos extract, fraction, or active fraction thereof
Sei-Ryang Oh, Daejeon (KR); Kyung Seop Ahn, Daejeon (KR); Su Ui Lee, Daejeon (KR); Hyung Won Ryu, Daejeon (KR); Doo-Young Kim, Daejeon (KR); Hyeong Kyu Lee, Daejeon (KR); Ok-Kyoung Kwon, Daejeon (KR); Jung Hee Kim, Daejeon (KR); Hyun-Jun Lee, Daejeon (KR); and In-Sik Shin, Gwangju (KR)
Assigned to KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, Daejeon (KR)
Appl. No. 15/573,207
Filed by KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, Daejeon (KR)
PCT Filed May 13, 2016, PCT No. PCT/KR2016/005113
§ 371(c)(1), (2) Date Nov. 10, 2017,
PCT Pub. No. WO2016/182399, PCT Pub. Date Nov. 17, 2016.
Claims priority of application No. 10-2015-0066621 (KR), filed on May 13, 2015.
Prior Publication US 2018/0353561 A1, Dec. 13, 2018
Int. Cl. A61K 36/575 (2006.01); A61P 11/00 (2006.01); A61K 31/34 (2006.01); A61K 31/36 (2006.01); A61P 9/00 (2006.01); A61P 35/00 (2006.01); A61K 31/357 (2006.01); A61K 9/00 (2006.01); A61K 47/38 (2006.01)
CPC A61K 36/575 (2013.01) [A61K 31/34 (2013.01); A61K 31/357 (2013.01); A61K 31/36 (2013.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 35/00 (2018.01); A61K 9/0019 (2013.01); A61K 9/0095 (2013.01); A61K 47/38 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A method for treating chronic obstructive pulmonary disease in a subject in need thereof, which comprises administering a pharmaceutically effective amount of (i) an extract of Magnoliae flo, (ii) an active fraction obtained by fractionation of the extract of Magnoliae flos with an organic solvent, or (iii) a combination of (i) and (ii) to the subject.